Effective palliation and quality of life outcomes in studies of surgery for advanced, non-curative gastric cancer: a systematic review
- 5 July 2011
- journal article
- review article
- Published by Springer Nature in Gastric Cancer
- Vol. 15 (S1) , 138-145
Abstract
Relief of symptoms should be the primary focus of palliative treatment as defined by the World Health Organization. Evaluating the effectiveness of palliative interventions should incorporate this goal and include quality of life (QOL) outcome assessments. A systematic review of the surgical gastric cancer literature was performed to summarize the effectiveness of palliative surgical interventions in addressing QOL. An electronic literature search of EMBASE, Medline, and the Cochrane Database of Controlled Trials was performed from January 1, 1985 to December 1, 2009. English language abstracts and articles were reviewed independently by two reviewers. A systematic approach to data abstraction and presentation was followed. No articles were identified as reporting true QOL outcomes using reliable, validated QOL instruments in surgically managed, advanced gastric cancer patients. Nine articles were identified as reporting outcomes measuring effectiveness of palliation. Commonly reported pre-procedure symptoms were weight loss, abdominal pain, vomiting, obstruction, and bleeding. Time to oral intake was reported in 5 of 9 studies, ranging from a mean of 2.9 days (laparoscopic gastrojejunostomy) to 8 days (surgical bypass). Length of postoperative inpatient stay ranged from a mean of 7 days (gastrojejunostomy) to 28 days (surgical bypass). Other measures of effective palliation included measures of clinical success, hospital re-admission rates, and post-procedure analgesic intake. A paucity of literature exists regarding the QOL of surgically managed gastric cancer patients. Prospectively designed studies using credible QOL measures are necessary to better inform the treatment decision-making process for these patients.Keywords
This publication has 35 references indexed in Scilit:
- Prospective evaluation of the reliability, validity, and minimally important difference of the functional assessment of cancer therapy‐gastric (FACT‐Ga) quality‐of‐life instrumentCancer, 2010
- Extent of Gastric Resection Impacts Patient Quality of Life: The Dysfunction after Upper Gastrointestinal Surgery for Cancer (DAUGS32) Scoring SystemAnnals of Surgical Oncology, 2010
- Quality of Life of Long-Term Survivors after a Distal Subtotal GastrectomyCancer Research and Treatment, 2010
- The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy aloneTrials, 2009
- Gastric cancerCritical Reviews in Oncology/Hematology, 2009
- Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trialQuality of Life Research, 2009
- Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trialBritish Journal of Cancer, 2008
- Self-expandable metallic stent placement for palliation in gastric outlet obstructions caused by gastric cancer: a comparison with surgical gastrojejunostomyJournal of Gastroenterology, 2005
- Gastrectomy for gastric cancer: defining critical elements of patient selection and outcome assessmentSurgical Oncology Clinics of North America, 2004
- Defining palliative surgery in patients receiving noncurative resections for gastric cancer1Journal of the American College of Surgeons, 2004